Trump urged historians to remember that the “great discoveries” that will end Covid-19 “all took place on my watch.”
Category: Editors’ Pick
Pfizer And Moderna Have Both Posted Great Vaccine Data. Here’s What’s Next
Dr. Stephen Thomas, an infectious diseases physician-scientist and the principal investigator for the Pfizer / BioNTech Covid vaccine trial occurring at SUNY Upstate Medical University, discusses what the next steps are for Pfizer and Modern’s vaccines.
WHO Chief Warns Vaccine Won’t End Covid-19 Pandemic As Moderna, Pfizer Announce Early Successes
The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.
Michigan, Washington Order New Covid-19 Restrictions As U.S. Cases Surge Past 11 Million
The U.S. has reported more than a million new cases in less than a week.
Expert Warns Cold Chain Infrastructure Overhaul Needed For Covid-19 Vaccine Rollout
Lenias Hwenda, an immunologist and international health expert from Zimbabwe has warned the cold-chain logistics of distributing an RNA vaccine for Covid-19 are going to be challenging for most lower-middle-income countries and rural areas. #globalso…
Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs
Any first-mover advantage won’t last long, as some vaccine candidates may be easier to transport and administer than others.
More Infectious And Airborne Covid-19 Mutant Replaced Wuhan Virus To Dominate Worldwide, Research Finds
The researchers believe current vaccine efforts should still be effective on the strain.
Amwell Launches New Products As It Posts First Earnings Since IPO
The Boston-based telehealth company beat revenue expectations but missed on earnings per share.
Black And Asian People More Likely To Catch Covid-19 In U.S. And U.K., Study Finds
Asian people are also more likely to be admitted to hospital for intensive care with Covid-19, the researchers found.
Fear Of Covid-19 Might Make Cancer Survivors Less Likely To Enroll In Clinical Trials: Study
The reasons for the cancer survivors who were less likely to enroll for clinical trials was the fear of increased COVID-19 exposure or having difficulties in accessing health care during the pandemic.
